Editor's Note Thirty-day data from the 225-patient LUCY (Evaluation of FemaLes who are Underrepresented Candidates for Abdominal Aortic AneurYsm Repair) Study showed that at least 28% more women became eligible for  minimally invasive endovascular abdominal aortic aneurysm (AAA) repair when using Endologix’s (Irvine, California) Ovation abdominal stent graft system, according…

Read More

Editor's Note The Food and Drug Administration (FDA) on May 23 identified the recall by Abbott-Thoratec (Pleasanton, California) of its HeartMate II Left Ventricular Assist (LVAS) Pocket System Controller as Class I, the most serious. Abbott-Thoratec has receives 70 reports of incidents in which the controller malfunctions after an exchange,…

Read More

Editor's Note The Food and Drug Administration on May 16 announced the recall by Abbott of specific lots of three coronary dilation and balloon catheters: NC Trek RX Coronary Dilation Catheter NC Traveler Coronary Dilation Catheter NC Tenku RX PTCA Balloon Catheter. The affected lots were manufactured between January 2015…

Read More

Editor's Note Conscious sedation is a safe and viable option for anesthesia in patients having transcatheter aortic valve replacement (TAVR), finds this study. The use of conscious sedation rather than general anesthesia was associated with: similar rates of adverse events (1.5% in both groups) shortened ICU (30 vs 96 hours)…

Read More

Editor's Note In an interim final rule, the Centers for Medicare and Medicaid Services (CMS) has delayed expansion of the Comprehensive Care for Joint Replacement (CJR) bundled payment program and  implementation of its bundled payment programs for cardiac care from July 1 to October 1, 2017, the March 20 Modern…

Read More

Editor's Note The Food and Drug Administration (FDA) on March 18 issued a Safety Alert for Abbott Vascular’s (Santa Clara, California) Absorb GT1 Bioresorbable Vascular Scaffold (BVS). The alert was issued to inform healthcare providers of an increased rate of major adverse cardiac events in patients receiving the BVS, when…

Read More

Editor's Note In this study, the composite outcomes of death, stroke, myocardial infarction, renal failure, or repeat revascularization at 5 year follow-up were similar for patients who had off-pump and on-pump coronary artery bypass grafting (CABG) procedures. The researchers also found no significant difference in cost or quality of life…

Read More

Editor's Note Surgical site infection (SSI) risk for coronary artery bypass graft (CABG) and hip arthroplasty patients is highest in hospitals with low annual procedure volumes, yet these hospitals are excluded from quality reporting, this study finds. Even for high-volume hospitals, year-to-year variation in SSI rates makes past performance an…

Read More

Editor's Note The Joint Commission on December 7 announced that it is offering a new Comprehensive Cardiac Center Certification, starting January 1. The voluntary program has been developed to recognize accredited hospitals that demonstrate excellence in delivering cardiac care through a combination of standards compliance, performance on targeted metrics, and…

Read More

Editor's Note A global outbreak of Mycobacterium chimaera has been linked to heater-cooler devices used in cardiac surgery, this study finds. Investigators found M chimaera in heater-cooler device water circuits and air samples while the devices were running, suggesting airborne transmission from the device to the surgical site. New heater-cooler…

Read More